<SEC-DOCUMENT>0001213900-19-020155-index.html : 20191011
<SEC-HEADER>0001213900-19-020155.hdr.sgml : 20191011
<ACCEPTANCE-DATETIME>20191010181916
ACCESSION NUMBER:		0001213900-19-020155
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20191010
FILED AS OF DATE:		20191011
DATE AS OF CHANGE:		20191010

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Therapix Biosciences Ltd.
		CENTRAL INDEX KEY:			0001611746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38041
		FILM NUMBER:		191146806

	BUSINESS ADDRESS:	
		STREET 1:		4 ARIEL SHARON STREET
		STREET 2:		HASHAHAR TOWER, 16TH FLOOR
		CITY:			GIV?ATAYIM
		STATE:			L3
		ZIP:			5320047
		BUSINESS PHONE:		972-3-6167055

	MAIL ADDRESS:	
		STREET 1:		4 ARIEL SHARON STREET
		STREET 2:		HASHAHAR TOWER, 16TH FLOOR
		CITY:			GIV?ATAYIM
		STATE:			L3
		ZIP:			5320047
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>f6k101019_therapixbio.htm
<DESCRIPTION>CURRENT REPORT OF FOREIGN ISSUER
<TEXT>
Document 1 - file: f6k101019_therapixbio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f6k101019ex99-1_therapixbio.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON OCTOBER 10, 2019, TITLED "THERAPIX BIOSCIENCES PROVIDES UPDATE ON PLANNED MERGER WITH DESTINY BIOSCIENCES GLOBAL CORP."
<TEXT>
Document 2 - file: f6k101019ex99-1_therapixbio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: image_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>